ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
Panacea Acquisition Corp

Panacea Acquisition Corp (NUVB)

2.28
-0.10
(-4.20%)
終了 2月11日 6:00AM
2.28
0.00
( 0.00% )
プレマーケット: 7:35PM

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

通貨
2.28
買値
-
売値
-
出来高
-
0.00 日の範囲 0.00
1.65 52 週間の範囲 4.1598
時価総額
前日終値
2.28
始値
-
時刻
最終取引時間
-
財務取引量
-
VWAP
-
平均取引量 (3 か月)
2,552,070
発行済株式数
336,566,525
配当利回り
-
PER
-10.12
1 株当たり利益 (EPS)
-0.23
歳入
-
純利益
-75.8M

Panacea Acquisition Corp について

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's proprietary portfolio includes around six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of t... Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's proprietary portfolio includes around six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
Panacea Acquisition Corp is listed in the Pharmaceutical Preparations sector of the ニューヨーク証券取引所 with ticker NUVB. The last closing price for Panacea Acquisition was US$2.28. Over the last year, Panacea Acquisition shares have traded in a share price range of US$ 1.65 to US$ 4.1598.

Panacea Acquisition currently has 336,566,525 shares in issue. The market capitalisation of Panacea Acquisition is US$767.37 million. Panacea Acquisition has a price to earnings ratio (PE ratio) of -10.12.

NUVB 最新ニュース

Nuvation Bio Announces Expanded Access Program in the U.S. for Taletrectinib in Advanced ROS1-positive Non-Small Cell Lung Cancer

Nuvation Bio Inc. (NYSE: NUVB), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced it has initiated an Expanded Access Program (EAP) for...

Nuvation Bio to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Nuvation Bio Inc. (NYSE: NUVB), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced that David Hung, M.D., Founder, President, and Chief...

Nuvation Bio Receives Approval from China’s National Medical Products Administration for Taletrectinib for Patients with Advanced ROS1-positive Non-Small Cell Lung Cancer

Taletrectinib will be marketed in China by Innovent Biologics Approval is based on the pivotal Phase 2 TRUST-I study, demonstrating taletrectinib's durable responses and prolonged...

U.S. Food and Drug Administration Accepts for Priority Review Nuvation Bio’s New Drug Application for Taletrectinib for the Treatment of Advanced ROS1-positive Non-Small Cell Lung Cancer

New Drug Application (NDA) is based on pooled data from the pivotal Phase 2 TRUST-I and TRUST-II studies of taletrectinib that demonstrated durable responses and prolonged progression-free...

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration PR Newswire SAN FRANCISCO and SUZHOU, China, Dec. 20...

Nuvation Bio to Present at the 7th Annual Evercore ISI HealthCONx Conference

Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced that David Hung, M.D., Founder...

Nuvation Bio to Present at the Jefferies London Healthcare Conference

Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced that David Hung, M.D., Founder...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.031.333333333332.252.472.2317490122.38390883CS
4-0.36-13.63636363642.642.822.22523396292.48281175CS
12-0.22-8.82.53.4552.22525520702.6996817CS
26-0.53-18.86120996442.813.455220619622.67754839CS
520.528.08988764041.784.15981.6517797282.82361274CS
156-3.33-59.35828877015.616.020.9511349212.64462441CS
260-7.72-77.21015.230.9510718194.15890842CS

NUVB - Frequently Asked Questions (FAQ)

What is the current Panacea Acquisition share price?
The current share price of Panacea Acquisition is US$ 2.28
How many Panacea Acquisition shares are in issue?
Panacea Acquisition has 336,566,525 shares in issue
What is the market cap of Panacea Acquisition?
The market capitalisation of Panacea Acquisition is USD 767.37M
What is the 1 year trading range for Panacea Acquisition share price?
Panacea Acquisition has traded in the range of US$ 1.65 to US$ 4.1598 during the past year
What is the PE ratio of Panacea Acquisition?
The price to earnings ratio of Panacea Acquisition is -10.12
What is the reporting currency for Panacea Acquisition?
Panacea Acquisition reports financial results in USD
What is the latest annual profit for Panacea Acquisition?
The latest annual profit of Panacea Acquisition is USD -75.8M
What is the registered address of Panacea Acquisition?
The registered address for Panacea Acquisition is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Panacea Acquisition website address?
The website address for Panacea Acquisition is ecor1cap.com
Which industry sector does Panacea Acquisition operate in?
Panacea Acquisition operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
ETBEaton Vance Tax Managed Buy Write Income Fund
US$ 23.59
(57.79%)
1
ETYEaton Vance Tax Managed Diversified Equity Income Fund
US$ 24.19
(55.76%)
1
LZMLifezone Metals Limited
US$ 8.99
(53.15%)
1
SLQTSelectQuote Inc
US$ 5.84
(33.33%)
338.15k
TACTransAlta Corporation
US$ 13.79
(28.28%)
6
SDHYPGIM Short Duration High Yield Opportunities Fund
US$ 11.01
(-33.71%)
4
KFKorea Fund Inc
US$ 14.01
(-30.44%)
11
AMTBAmerant Bancorp Inc
US$ 17.01
(-26.68%)
6
GNEGenie Energy Ltd
US$ 11.20
(-22.06%)
10
ZIPZipRecruiter Inc
US$ 6.33
(-21.76%)
4
BBAIBigBear ai Holdings Inc
US$ 8.43
(-3.33%)
700.52k
SLQTSelectQuote Inc
US$ 5.84
(33.33%)
338.15k
ACHRArcher Aviation Inc
US$ 10.30
(0.98%)
268.42k
NIONIO Inc
US$ 4.24
(-2.08%)
223.8k
SESSES AI Corporation
US$ 1.15
(-0.86%)
218.39k

NUVB Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock